Markets
BridgeBio at Wells Fargo conference: growth plan centers on 2027 launches
The business is growing strongly, led by acoramidis and a late-stage pipeline with three major launches by 2027. ATTR-CM stabilizers are frontline, with Attruby set for greater market share. Launches in limb-girdle musc…